Streamex Corp. — Director's Dealing 2019

May 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2019-05-21

Reporting Person: ZELDIS JEROME B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-21	Common Stock	C	13334	$3.75	Acquired	82043	Direct
2019-05-21	Common Stock	A	3804	$7.44	Acquired	85847	Direct
2019-05-22	Common Stock	M	20000	$3.40	Acquired	105847	Direct
2019-05-22	Common Stock	M	1097	$6.85	Acquired	106944	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-21	Series C Preferred Stock	$3.75	C	50	Disposed		Common Stock (13334)	Direct
2019-05-22	Options to Purchase Common Stock	$3.40	M	20000	Disposed	2026-12-22	Common Stock (20000)	Direct
2019-05-22	Warrants to Purchase Common Stock	$6.85	M	1097	Disposed	2021-08-17	Common Stock (1097)	Direct

Footnotes

F1: Each share of the Series C Preferred Stock is entitled to a nine percent (9%) annual dividend on the $1,000 per share stated value. The dividends accrued and became payable in cash or, at the Issuer's option and subject to the satisfaction of certain conditions, in pay-in-kind shares. Such cumulative dividends were payable quarterly, commencing on September 30, 2013, thereafter quarterly on December 31, March 31, June 30 and September 30, and on the conversion date. The reporting person's 50 shares of Series C Preferred Stock were converted on May 21, 2019, and the Issuer elected to pay the accrued dividends in pay-in-kind shares. Pursuant to the terms of the Series C Preferred Stock and using the price calculated pursuant to the terms of the Series C Preferred Stock, the reporting person received 3,804 shares of common stock as a payment-in-kind dividend upon conversion of 50 shares of Series C Preferred Stock owned by the reporting person on the conversion date.

F2: The Series C Preferred Stock could be converted at any time at the option of the holder into shares of common stock at a conversion price of $3.75 per share. The Series C Preferred Stock had no expiration date.